Dergiler / Acta Medica / 2021 / Cilt: 52 - Sayı: 2

Conventional to Early Phase Standardized Uptake Value Ratio on 18F FDG PET/CT Could Reflect Prognosis in Patients with Non-small Cell Lung Cancer

Sayfa
136–144
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

There is a need for studies with larger groups of patients.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: A high metabolism/perfusion rate in the tumor is known to be factor indicating poor prognosis.
📊
Temel Bulgular & Veri:Materials and Methods: Early-phase imaging was obtained in the first 120 seconds and conventional imaging was taken after median 66 minutes.
💡
Sonuç & Katkı:There is a need for studies with larger groups of patients.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: A high metabolism/perfusion rate in the tumor is known to be factor indicating poor prognosis. The goal of this study was to investigate the prognostic value of the ratio of the conventional standard uptake value to early-phase imaging standard uptake value in patients with newly diagnosed non-small cell lung cancer. Materials and Methods: Early-phase imaging was obtained in the first 120 seconds and conventional imaging was taken after median 66 minutes. The ratio of the conventional standard uptake value to earlyphase imaging standard uptake value was calculated. Univariate and multivariate analyses were performed using the Cox proportional hazards regression model to assess the relationship between progression-free survival and ratio of the conventional standard uptake value to early-phase imaging standard uptake. Results: A total of 77 patients with non-small cell lung cancer were recruited. Progression-free survival analysis was performed in 52 inoperable patients. Progression-free survival was found to be related to conventional standard uptake value (p<0.001), tumor size (p<0.001) and ratio of the conventional standard uptake value to early-phase imaging standard uptake in univariate analysis (p=0.047). In the multivariate analysis, ratio of the conventional standard uptake value to early-phase imaging standard uptake (p=0.001, HR=1.145, 95CI%:1.145-1.719) and tumor size (p<0.001, HR=1.026, 95CI%:1.007-1.045) were found to be independent poor prognostic factors. Conclusion: The ratio of the conventional standard uptake value to earlyphase imaging standard uptake was found an indicator for prognosis. Evaluating the early phase imaging, without a need for kinetic program or software, without disrupting the routine functioning of the clinic, with conventional imaging may contribute to cancer patient management. There is a need for studies with larger groups of patients.

🔖

Bu Makaleye Atıf Yap

KUPIK, O., ASA, S., EREN, G. (2021). Conventional to Early Phase Standardized Uptake Value Ratio on 18F FDG PET/CT Could Reflect Prognosis in Patients with Non-small Cell Lung Cancer. Acta Medica, Cilt: 52 - Sayı: 2, 136–144. https://ajindex.com/articles/406494

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Takeda A, Yokosuka N, Ohashi T et al. The maximum standardized uptake value (SUVmax) on FDG-PET is a strong predictor of local recurrence for localized nonsmall-cell lung cancer after stereotactic body radiotherapy (SBRT). Radiother Oncol. 2011; 101: 291-7
  2. Imamura Y, Azuma K, Kurata S et al. Prognostic value of SUVmax measurements obtained by FDG-PET in patients with non-small cell lung cancer receiving chemotherapy. Lung Cancer. 2011; 71: 49-54
  3. Kohutek ZA, Wu AJ, Zhang Z et al. FDG-PET maximum standardized uptake value is prognostic for recurrence and survival after stereotactic body radiotherapy for nonsmall cell lung cancer. Lung Cancer. 2015; 89: 115- 20
  4. Semenza GL. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med. 2002; 8: S62-S7
  5. Clavo AC, Brown RS, Wahl RL. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J Nucl Med. 1995; 36: 1625-32
  6. Airley RE, Mobasheri A. Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Chemotherapy. 2007; 53: 233-56
  7. Brown JM, Wilson WR. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer. 2004; 4: 437-47
  8. Held KD. Radiobiology for the Radiologist, by Eric J. Hall and Amato J. Giaccia. Radiat Res. 2006; 166: 816-7
  9. Servagi-Vernat S, Differding S, Sterpin E et al. Hypoxiaguided adaptive radiation dose escalation in head and neck carcinoma: a planning study. Acta Oncol. 2015; 54: 1008-16
  10. Mullani N. et al. 9: 30—9: 45: First Pass FDG Measured Blood Flow in Tumors: A Comparison with O-15 Labeled Water Measured Blood Flow. Clinical Positron Imaging. 2000; 3: 153
  11. Mullani NA, Herbst RS, O’Neil RG, et al. Tumor blood flow measured by PET dynamic imaging of first-pass 18F-FDG uptake: a comparison with 15O-labeled water-measured blood flow. J Nucl Med. 2008; 49: 517-23
  12. Goethals I, Hanssens S, Kortbeek K, et al. Hypothesis using dynamic 18 F-FDG PET in oncology. Eur J Nucl Med Mol Imaging. 2010; 37: 833-833
  13. Mertens J, Ham H, De AZ, et al. Tumor perfusion using firstpass F-18 FDG PET images. Clin Nucl Med. 2012; 37: 166-7
  14. Komar G, Kauhanen S, Liukko K et al. Decreased blood flow with increased metabolic activity: a novel sign of pancreatic tumor aggressiveness. Clin Cancer Res. 2009; 15: 5511-7
  15. Hoekstra CJ, Stroobants SG, Hoekstra OS, et al. Measurement of perfusion in stage IIIA-N2 non-small cell lung